Sanofi is now leading talks to acquire Actelion following confirmation Johnson & Johnson has abandoned its pursuit of the Swiss company.

New Stories
-
NZ landscap
April 19, 2018 - -
PBS listing process descends into farce
April 19, 2018 - - Latest News -
A serious industry deserving of serious decisions
April 19, 2018 - - Comment -
Once contentious is now confusing
April 18, 2018 - - Latest News -
Sanofi sells European generics business
April 18, 2018 - - Latest News -
Seqirus announces PNG antivenom initiative
April 18, 2018 - - Latest News -
BMS and Janssen team up on new anticoagulant
April 18, 2018 - - Latest News